Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is an adaptive Phase I trial of a vaccine consisting of autologous dendritic cells previously loaded ex vivo with SARS-CoV-2 spike protein, with or without GM-CSF, to prevent COVID-19 in adults.
Epistemonikos ID: 71dde5bb05fe5db1ba86560903de3315942fb548
First added on: Dec 31, 2020